SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals
5 references·1 citing·27 second hop
Paying for Outcomes: Innovative Coverage and Reimbursement Schemes for Pharmaceuticals (2009)Paying for Outcomes: Innovative Coverage …Expanded Use Of Imaging Technology And The Challenge Of Measuring Value (2008)Expanded Use Of Imaging Techn…Value-Based Insurance Design (2007)Value-Based Insurance DesignPerformance-Based Contracting (2007)Performance-Based ContractingEconomic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer. (2005)Economic analysis of targetin…The price of innovation: new estimates of drug development costs (2003)The price of innovation: new …Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends (2017)Risk-Sharing Agreements in th…Is Technological Change In Medicine Worth It? (2001)The Implications of Regional Variations in Medicare Spending. Part 1: The Content, Quality, and Accessibility of Care (2003)The Implications of Regional Variations in Medicare Spending. Part 2: Health Outcomes and Satisfaction with Care (2003)Health Insurers and Medical-Imaging Policy — A Work in Progress (2009)Changes in the Use and Costs of Diagnostic Imaging Among Medicare Beneficiaries With Cancer, 1999-2006 (2010)Canada: Health System Review. (2013)Cost of innovation in the pharmaceutical industry (1991)Stocks, bonds, bills, and inflation yearbook (1993)Risks in new drug development: Approval success rates for investigational drugs (2001)Can the pharmaceutical industry reduce attrition rates? (2004)Clinical development success rates for investigational drugs (2014)Innovation in the pharmaceutical industry: New estimates of R&D costs (2016)Health insurance and the demand for medical care: evidence from a randomized experiment. (1987)UNCERTAINTY AND THE WELFARE ECONOMICS OF MEDICAL CARE (2003)The Future of Disability in America (2007)Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage (2009)The impact of health care reform on hospital and preventive care: Evidence from Massachusetts (2012)American Economic Review (2019)Research Design: Qualitative, Quantitative, and Mixed Methods Approaches (1994)Qualitative Content Analysis (2008)The Use of Qualitative Content Analysis in Case Study Research (2008)Outcome-based contracts as a driver for systems thinking and service-dominant logic in service science: Evidence from the defence industry (2009)Performance-Based Contracting for Maintenance (2009)Advanced multicriteria models to promote quality and reputation in public construction e-marketplaces (2012)Personalized medicine: Factors influencing reimbursement (2009)Cost-Effectiveness Analysis of Recurrence Score-Guided Treatment Using a 21-Gene Assay in Early Breast Cancer (2010)Economic Implications of 21-Gene Breast Cancer Risk Assay from the Perspective of an Israeli-Managed Health-Care Organization (2010)
this work references cited by second hop

References

  • 2003The price of innovation: new estimates of drug development costs4,312 cited
  • 2008Expanded Use Of Imaging Technology And The Challenge Of Measuring Value443 cited
  • 2007Value-Based Insurance Design347 cited
  • 2005Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.224 cited
  • 2007Performance-Based Contracting29 cited

Cited by

  • 2017Risk-Sharing Agreements in the EU: A Systematic Review of Major Trends47 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work